Finance

Lists
Why is ATHE down 2.79%?
Dive Deeper
ATHE:NASDAQ
Alterity Therapeutics Ltd
$2.09
-2.79%
(-0.060) 1D
Oct 23, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATHE...
Open
$2.12
High
$2.43
Low
$2.04
Mkt. cap
41.48M
Avg. vol.
25.78K
Volume
26.79K
52-wk high
$5.89
52-wk low
$2.04
EPS
-$0.94
Beta
0.29
Shares outstanding
19.10M
No. of employees
11
Open
$2.12
High
$2.43
Low
$2.04
Mkt. cap
41.48M
Avg. vol.
25.78K
Volume
26.79K
52-wk high
$5.89
52-wk low
$2.04
EPS
-$0.94
Beta
0.29
Shares outstanding
19.10M
No. of employees
11
News stories
From web sources and news partners
About Alterity Therapeutics Ltd
CEO-
Employees11
Founded1997
HeadquartersMelbourne, Victoria, Australia
SectorBiotechnology
Analyst ratings
Based on 3 analysts giving stock ratings to ATHE in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ATHE in the last 3 months.
Highest
Current $2.09
$16.00 (+665.55%)
Average
$13.67 (+554.07%)
Lowest
$10.00 (+378.47%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Flaten
Lake Street
Buy
Maintained
$10.00
+378.5%
10/05/2026
Adam Vogel
Craig-Hallum
Buy
Reiterated
$15.00
+617.7%
10/05/2026
Debanjana Chatterjee
JonesTrading
Buy
Maintained
$16.00
+665.6%
08/28/2026
Caroline Palomeque
Ladenburg Thalmann & Co.
Buy
Initiated
$10.00
+378.5%
06/16/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Initiated
$10.00
+378.5%
06/16/2026
Jason McCarthy
Maxim Group
Buy
Reiterated
$12.00
+474.2%
06/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
-343.00%
-343.00%
-1,709.06%
-1,709.06%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps